An access committee will accept/decline applications for the use of biological material in projects based on scientific strength and relevance. The national part of the biobank has an extended access committee comprising one hematologist from the University Hospitals in all four Regional Health Authorities in Norway. The material in the general biobank is generally available unless the provider of the material has any exclusivity attached to a specific project for a time-limited period. For additional information and application form, please contact Biobank1®.
The Center for Myeloma Research, NTNU, covers several aspects including basic and translational research, and clinical studies on multiple myeloma. Selected research topics are hepatocyte growth factor, bone morphogenetic protein, c-myc, exome sequencing, circulating tumor DNA, myeloma bone disease and Phase II-III clinical trials. For additional information, see https://www.ntnu.edu/myeloma/research